Stocks · US
IDXX
XNAS
Idexx Laboratories Inc
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E36.43x
P/B25.75x
P/S9.12x
EPS$14.47
ROE70.67%
ROA33.11%
Dividend yield0.00%
EV/EBITDA26.23x
Debt/Equity0.60
Free cash flow$1.3B
Returns and 52-week range
1W-3.38%
1M-3.73%
3M-7.25%
6M-10.33%
1Y-18.34%
YTD-23.07%
52W high$769.98
52W low$500.61
From 52W high-33.06%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Waters Corp | $43.2B | 260.27 | 2.85 | +6.61% |
| BeOne Medicines Ltd. American Depositary Shares | $40.9B | 62.39 | 7.91 | +1.26% |
| 아이큐비아 홀딩스 | $43.8B | 31.85 | 7.10 | -2.91% |
| Biogen Inc. Common Stock | $33.0B | 39.58 | 1.75 | +0.93% |
| Illumina Inc | $44.3B | 53.75 | 15.63 | +25.35% |
| DexCom, Inc. | $32.8B | 32.80 | 12.51 | -5.13% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.